Vascular Discovery 2026 Scientific Sessions  /  04. Concurrent Session 1b: Peripheral Artery Disease, Aortic Aneurysm, and Cerebrovascular Disease  /  New mechanisms and biomarkers in abdominal aortic aneurysms
Logo

American Heart Association

  41
  0

Final ID:

New mechanisms and biomarkers in abdominal aortic aneurysms

  • Cameron, Scott  ( CLEVELAND CLINIC , Solon , Ohio , United States )
    • Author Disclosures:
    Scott Cameron: DO NOT have relevant financial relationships
Meeting Info:

Vascular Discovery 2026 Scientific Sessions

2026

Bellevue, Washington

Session Info:

04. Concurrent Session 1b: Peripheral Artery Disease, Aortic Aneurysm, and Cerebrovascular Disease

Thursday, 05/14/2026 , 10:30AM - 12:00PM

Oral

More abstracts on this topic:
Discovery of VS-214, a long-acting apelin agonist, as a first-in-class treatment of peripheral artery disease (PAD).

Vekich John, Plonowski Artur, Cole Derek, Krupa Magdalena, Pratt Benjamin, Berger Joel, Bochenek Wieslaw, Walker Gennyne, Palaniswamy Kiruthi, Henig Noreen

Nanoparticle-Mediated PIEZO1 Modulation to Halt Macrophage-Driven PAD Progression Through Targeting PIEZO1-Notch1 Signaling

Zhao Fujie, Yang Lily, Brewster Luke, Zhu Lei, Sasaki Maiko, Sanchez Marrero Gloriani, Allan Miller, Chou Kevin, Fernandez Jacob, Chung Kim Dae Guang, Ranjan Shivangi

More abstracts from these authors:
DIAGNOSIS TO RECOVERY: PSYCHOLOGICAL DISTRESS IN PULMONARY EMBOLISM

Rajasekar Bhairavi, Hurley Karen, Cameron Scott, Tefera Leben

The Transition of Platelets from Sealants to Signalers in Abdominal Aortic Aneurysm Protection via TGFβ1

Spuzzillo Anthony, Benson Tyler, Cameron Scott, Owens Iii A. Phillip

You have to be authorized to contact abstract author. Please, Login
Not Available